BioSpace News Archive

Cirius Therapeutics, a clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and metabolic diseases, announced today that Elaine D. Sun, M.B.A., has been appointed to the company’s board of directors as an independent director.

Operational Profitability and Improved Net Margins Remain Top Priorities

Award Supports Advancement of BIOC51 Through Toxicology Studies in 2019

The Gallery, Pierce County marijuana retailers, partnered with the Carol Milgard Breast Center to raise money during Breast Cancer Awareness month

Surterra Wellness (Surterra), one of the fastest growing health and wellness companies in the United States, today announced the Texas launch of Tranquil™, a high-CBD, low-THC medical cannabis tincture for patients living with intractable epilepsy.

A fast, sensitive, specific and accurate detection method to determine active infection

The policy advances PCORI’s commitment to improve healthcare decision making based upon research.

FMM made this decision after careful strategic consideration for opportunities to generate greater critical mass and serve a greater number of patients and families.

Presents MATRIX Clinical Trial Data and Holds Clinical Advisory Board Meeting on the use of Excellagen for the Treatment of Diabetic Ulcers and Surgical Wounds

CIT Group Inc. (NYSE: CIT) today announced that its Healthcare Finance business, part of CIT’s Commercial Finance division, served as sole lead arranger of $21.4 million in senior secured credit facilities for Virtus Real Estate Capital, a private equity real estate firm that focuses on cycle-resilient alternative property types.